Osaic Holdings
NVO

Osaic Holdings’s Novo Nordisk NVO Stock Holding History

Osaic Holdings’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Sell
323,855
-18,622
-5% -$800K 0.02% 780
2026
Q1 		$12.6M Buy
342,477
+43,148
+14% +$2.04M 0.02% 774
2025
Q4 		$15.2M Sell
299,329
-75,352
-20% -$3.85M 0.02% 706
2025
Q3 		$21M Buy
374,681
+3,351
+0.9% +$196K 0.03% 600
2025
Q2 		$25.7M Buy
371,330
+113,518
+44% +$7.72M 0.05% 410
2025
Q1 		$17.9M Buy
257,812
+17,148
+7% +$1.42M 0.04% 450
2024
Q4 		$20.7M Sell
240,664
-65,914
-21% -$7.13M 0.05% 389
2024
Q3 		$36.5M Sell
306,578
-69,340
-18% -$9.25M 0.08% 241
2024
Q2 		$53.7M Buy
375,918
+12,080
+3% +$1.6M 0.13% 158
2024
Q1 		$46.7M Sell
363,838
-174,270
-32% -$20.7M 0.1% 193
2023
Q4 		$55.7M Sell
538,108
-106,767
-17% -$10.6M 0.1% 195
2023
Q3 		$58.7M Buy
644,875
+226,013
+54% +$19.9M 0.09% 211
2023
Q2 		$33.8M Buy
418,862
+42,842
+11% +$3.5M 0.06% 287
2023
Q1 		$29.9M Buy
376,020
+33,364
+10% +$2.37M 0.06% 319
2022
Q4 		$23.2M Buy
342,656
+2,552
+0.8% +$150K 0.05% 387
2022
Q3 		$16.9M Buy
340,104
+7,618
+2% +$408K 0.04% 438
2022
Q2 		$18.5M Buy
332,486
+86,146
+35% +$4.78M 0.04% 409
2022
Q1 		$12.3M Buy
246,340
+48,218
+24% +$2.47M 0.02% 647
2021
Q4 		$11.1M Buy
198,122
+19,988
+11% +$1.08M 0.02% 689
2021
Q3 		$8.55M Buy
178,134
+11,476
+7% +$555K 0.02% 743
2021
Q2 		$6.99M Buy
166,658
+16,918
+11% +$656K 0.02% 842
2021
Q1 		$5.05M Buy
149,740
+4,954
+3% +$176K 0.01% 963
2020
Q4 		$5.06M Sell
144,786
-344
-0.2% -$11.9K 0.01% 861
2020
Q3 		$5M Sell
145,130
-13,488
-9% -$450K 0.02% 757
2020
Q2 		$5.19M Sell
158,618
-37,846
-19% -$1.21M 0.02% 676
2020
Q1 		$4.79M Buy
+196,464
New +$5.85M 0.02% 628

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Osaic Holdings's NVO Position: Q2 2026 in Review

Osaic Holdings reduced its Novo Nordisk (NVO) stake by 5.4% in Q2 2026, selling an estimated $800K and leaving 323,855 shares worth $15.5M. The position accounts for 0.02% of the portfolio, ranked #780.

Osaic Holdings first reported a position in NVO in Q1 2020 and has held it in 26 quarters since. The position peaked at $58.7M in Q3 2023. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Osaic Holdings held 323,855 shares of Novo Nordisk worth $15.5M as of Q2 2026.
  • Osaic Holdings sold 18,622 Novo Nordisk shares in Q2 2026, an estimated $800K.
  • Novo Nordisk made up 0.02% of Osaic Holdings's portfolio in Q2 2026, its #780 holding.
  • Osaic Holdings first reported a position in Novo Nordisk in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Novo Nordisk position peaked at $58.7M in Q3 2023.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.